Traphaco

TRA

VN000000TRA8

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
81,900 ^VND	+0.37%		+0.37%	-7.98%

Apr. 26	Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 17	Traphaco Joint Stock Company Announces Board Changes	CI

Traphaco Joint Stock Company Appoints Kim Dong Hyu as Deputy Chief Executive Officer, Effective from October 01, 2019

September 09, 2019 at 05:06 am EDT

Traphaco Joint Stock Company appointed Mr. Kim Dong Hyu as Deputy Chief Executive Officer as from October 01, 2019.

Latest news about Traphaco

Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Traphaco Joint Stock Company Announces Board Changes	Apr. 16	CI
Traphaco Joint Stock Company Provides Consolidated Earnings Guidance for the Year 2024	Apr. 16	CI
Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Jan. 29	CI
Traphaco Joint Stock Company Announces Dividend Advance for the Year 2023, Payable on February 2, 2024	Dec. 18	CI
Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-27	CI
Traphaco Joint Stock Company Announces the Resignation of Kwon Ki Bum from the Position of Member of the Board of Supervisors	23-07-21	CI
Traphaco Joint Stock Company Approves the Second Dividend Payment for 2022, Payable on June 29, 2023	23-05-23	CI
Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-31	CI
Traphaco Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-31	CI
Traphaco Joint Stock Company Announces First Dividend for 2022, Payable on November 30, 2022	22-11-09	CI
Traphaco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-25	CI
Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-28	CI
Traphaco Joint Stock Company Approves the Second Dividend Payment of the Year 2021, Payable on June 27, 2022	22-05-17	CI
Traphaco Joint Stock Company Announces Resignation of Nguyen Anh Tuan as Vice Chairman of the Board of Directors	22-05-10	CI
Traphaco Joint Stock Company Appoints Nguyen Phu Khanh as Vice Chairman of the Board of Directors	22-05-10	CI
Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Traphaco Joint Stock Company Receives Lai Tran Dong's Resignation as Board Member	22-03-28	CI
Traphaco Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-01-27	CI
Traphaco Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-27	CI
Traphaco Joint Stock Company Announces Dividend Advance for the Year 2021, Payable on January 25, 2022	21-12-27	CI
Traphaco Joint Stock Company Announces Dismissal of Nguyen Thi Lan as Deputy CEO	21-12-17	CI
Traphaco Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-21	CI
Traphaco Joint Stock Company Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-20	CI

Traphaco Joint Stock Company is a Vietnam-based pharmaceutical manufacturer. The Company manufactures and trades pharmaceutical products, chemicals, functional food, cosmetic products and other medical equipment and supplies. It is also involved in the cultivation and processing of drug materials, medical technology transfer, as well as the provision of consulting services in the pharmaceutical industry. Other activities of the Company include manufacturing and trading beer, wine and soft drinks (excluding bar business). As of December 31, 2012, the Company had three subsidiaries operating in the similar industry. As of the same date, it had 14 branches.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

81,900 VND

Average target price

95,300 VND

Spread / Average Target

+16.36%

Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TRAPHACO	-7.98%	134M
NOVO NORDISK A/S	+21.85%	546B
JOHNSON & JOHNSON	-4.77%	359B
MERCK & CO., INC.	+16.97%	323B
ABBVIE INC.	+5.69%	290B
ASTRAZENECA PLC	+13.68%	234B
NOVARTIS AG	+3.65%	198B
ROCHE HOLDING AG	-11.12%	194B
AMGEN INC.	+8.08%	167B
PFIZER, INC.	-3.40%	157B

Other Pharmaceuticals

Traphaco

Equities

TRA

VN000000TRA8

Pharmaceuticals

Traphaco Joint Stock Company Appoints Kim Dong Hyu as Deputy Chief Executive Officer, Effective from October 01, 2019

Latest news about Traphaco

Chart Traphaco

Company Profile

Income Statement Evolution

Analysts' Consensus

Chiffre d''affaires - Rate of surprise

Sector Other Pharmaceuticals